Home › Funds › Arbiter Partners Capital Management LLC › RNA

Arbiter Partners Capital Management LLC position in RNA

ATRIUM THERAPEUTICS INC · Health Care

Arbiter Partners Capital Management LLC reported holding 311,719 shares of RNA (ATRIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.6M, representing 1.14% of its reported portfolio and ranking #17 among its reported holdings. Arbiter Partners Capital Management LLC has disclosed RNA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)311.72K sh
Reported value held$2.58M
Portfolio Weight1.14%
First reportedQ1 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Arbiter Partners Capital Management LLC's RNA position evolved

Arbiter Partners Capital Management LLC first disclosed a stake in RNA in Q1 2026 at 230,000 shares (US$3.1M). The position peaked in Q2 2026 at 261,288 shares, worth US$3.5M. Across 3 filings, Arbiter Partners Capital Management LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 311,719 shares valued at US$2.6M — an increase of 50,431 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 230.00K $3.08M New
Q2 2026 261.29K $3.51M Add
Q3 2026 311.72K $2.58M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RNA and 13F data

RNA (ATRIUM THERAPEUTICS INC) is a Health Care company. 98 other funds we track also report a position in RNA — the largest reported positions include Sessa Capital IM, L.P. (US$20.2M), TIG Advisors, LLC (US$7.6M), Slotnik Capital, LLC (US$3.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RNA

All RNA fund holders →

FAQ

How long has Arbiter Partners Capital Management LLC held RNA?

Arbiter Partners Capital Management LLC has disclosed RNA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Arbiter Partners Capital Management LLC's current position in RNA?

As of Q3 2026, Arbiter Partners Capital Management LLC holds 311.72K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $2.58M, representing 1.14% of its reported portfolio and ranking #17.

Has Arbiter Partners Capital Management LLC been buying or selling RNA?

In the latest 13F filing (Q3 2026), Arbiter Partners Capital Management LLC increased its position in RNA. The position peaked in Q2 2026 at 261.29K shares.

Which other funds hold RNA?

Other major institutional holders of RNA include Sessa Capital IM, L.P., TIG Advisors, LLC, Slotnik Capital, LLC, among 98 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.